Logistics firms invest millions to expand cold chain facilities amid rising demand for temperature-sensitive drugs like GLP-1s.

Shipping and logistics companies such as UPS, FedEx, DHL, and C.H. Robinson are heavily investing in temperature-controlled facilities to meet the growing demand for shipping specialized pharmaceuticals like GLP-1 weight loss drugs. These medications require strict refrigerated storage to maintain efficacy, driving logistics firms to enhance their cold chain infrastructure and technology. The healthcare logistics sector is rapidly expanding, with UPS reporting a $3 billion healthcare revenue quarter and FedEx nearing $10 billion in healthcare transportation revenue. This trend reflects the increasing complexity and volume of biologics and specialized therapies, prompting logistics companies to offer end-to-end visibility and control to ensure safe, timely delivery of critical medicines.